There won't be any major acquisitions this year despite the company sitting on $73.2 million in the bank, and an inflated stock price that it could use to help pay for a purchase.
There's a possibility of adding further growth externally, but management said that it's only considering smaller tuck-in acquisitions this year. In the second quarter, the company received FDA clearance to start selling its Quantum amplifier, which monitors brain function for patients who have epilepsy and seizures. Looking forward Natus is obviously pushing the service business model hard, but it certainly isn't abandoning medical products. Natus looks well on its way to reaching its goal of 18% operating profit margin goal for 2015, and 20% for 2016. Non-GAAP operating profit margin came in at a solid 18.5%, thanks to the aforementioned increases in Natus' service businesses, as well as further cost reductions like closing down a facility that it received in an acquisition. sales don't require middlemen distributors that get a cut of the profits. in the second quarter also helped increase the gross profit margin because, unlike foreign sales, U.S. Having a larger percentage of sales come from the U.S. Manufacturing in Europe acts as a natural hedge against lower sales when the dollar strengthens, because it lowers Natus' costs. Natus was able to book the larger year-over-year increase in income compared to revenue by driving its non-GAAP gross profit margin to 63.2%. The earning-per-share number would have been even worse if the company hadn't repurchased $4.2 million worth of stock during the quarter. Natus' non-GAAP net income actually increased by a more-impressive 25.8%, but the earnings-per-share number was dragged down by an increase in share count due to employee options that are clearly in the money with shares up 78% during the last year. The bottom line Non-GAAP earnings per diluted share came in at $0.34, topping guidance of between $0.31 and $0.33 per share, and beating last year's $0.28 per share by 21%. Natus thinks there could be an opportunity to move into the well-baby area, as well. Neonatal intensive-care units are clearly an easier grab for the service, which caters to friends and families who want to see the newborn, because babies in the unit stay in the hospital longer and access is limited. The service's video monitoring for neonatal intensive-care units is now in a little more than 50 hospitals in the U.S., and Natus has quotes out to 80 more.
Natus may also be known as or be related to Natus, Natus Medical, Natus Medical Incorporated and Natus Medical, Inc.NicView, which Natus only purchased in the first quarter of the year, is also poised to add substantial revenue. The data presented on this page does not represent the view of Natus and its employees or that of Zippia. None of the information on this page has been provided or approved by Natus. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. The employee data is based on information from people who have self-reported their past or current employments at Natus. Zippia gives an in-depth look into the details of Natus, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Natus.